The Impact of Concomitant Left Ventricular Non-compaction with Congenital Heart Disease on Perioperative Outcomes

Preeti Ramachandran1, Jessica G Woo2, Thomas D Ryan3

  • 1The Heart Institute, Cincinnati Children's Hospital, Cincinnati Children's Hospital Medical Center, 3333 Burnet Ave, Cincinnati, OH, 45229, USA. preeti.ramachandran@cchmc.org.

Insights

Children with left ventricular non-compaction (LVNC) and congenital heart disease (CHD) face significantly higher risks during surgery. These patients experienced longer hospital stays and more severe complications compared to those with CHD alone.

Area of Science:

  • Cardiology
  • Pediatric Cardiac Surgery
  • Cardiomyopathy Research

Background:

  • Left ventricular non-compaction (LVNC) is a myocardial disorder with prominent trabeculations, often co-occurring with congenital heart disease (CHD).
  • The impact of concomitant LVNC on surgical outcomes in pediatric CHD patients remains understudied.

Purpose of the Study:

  • To evaluate the perioperative outcomes of pediatric patients with LVNC and CHD (LVNC-CHD) undergoing surgery.
  • To compare surgical outcomes between LVNC-CHD patients and a control group of CHD-only patients.

Main Methods:

  • Retrospective review of pediatric patients (0-5 years) diagnosed with LVNC-CHD who underwent surgery.
  • Comparison with a matched control group of pediatric patients (0-5 years) with CHD but without LVNC (CHD-only).
  • Collection and analysis of perioperative data, including length of hospital stay and postoperative complications.

Main Results:

  • LVNC-CHD patients had a significantly longer median hospital stay (12.5 days) compared to CHD-only patients (5 days).
  • A higher rate of severe adverse events (postoperative death, cardiac arrest, ECMO, or transplantation) was observed in LVNC-CHD patients (30%) versus CHD-only patients (1%).
  • LVNC-CHD patients experienced significantly increased perioperative complications compared to CHD-only controls.

Conclusions:

  • Concomitant LVNC in pediatric CHD patients is associated with substantially increased perioperative risks and longer hospitalizations.
  • Pediatric cardiac care teams must recognize the heightened risks in LVNC-CHD patients.
  • Further prospective studies are necessary to fully elucidate the implications of LVNC in pediatric CHD surgery.

Related Concept Videos

Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
416
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
3.4K
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
1.1K
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
636
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
591
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
2.2K